Genus (GNS) Competitors

Genus logo
GBX 2,272 -60.00 (-2.57%)
As of 06:09 AM Eastern

GNS vs. IGG, SMWH, CPG, ALLG, and CVSG

Should you buy Genus stock or one of its competitors? Genus's main competitors and comparable companies include IG Group (IGG), WH Smith (SMWH), Compass Group (CPG), ALLG.L (ALLG), and CVS Group (CVSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "diversified consumer services" industry.

How does Genus compare to IG Group?

IG Group (LON:IGG) and Genus (LON:GNS) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

IG Group has a net margin of 52.85% compared to Genus' net margin of 43.35%. Genus' return on equity of 44.90% beat IG Group's return on equity.

Company Net Margins Return on Equity Return on Assets
IG Group52.85% 19.10% 10.37%
Genus 43.35%44.90%3.31%

IG Group currently has a consensus price target of GBX 1,537.50, suggesting a potential upside of 57.90%. Genus has a consensus price target of GBX 3,216.67, suggesting a potential upside of 37.82%. Given IG Group's higher possible upside, research analysts plainly believe IG Group is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IG Group
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

IG Group has higher revenue and earnings than Genus. Genus is trading at a lower price-to-earnings ratio than IG Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IG Group£949.10M3.38£533.35M£105.109.26
Genus£658.10M2.29£7.87M£425.105.49

74.0% of IG Group shares are owned by institutional investors. Comparatively, 55.3% of Genus shares are owned by institutional investors. 1.2% of IG Group shares are owned by company insiders. Comparatively, 0.8% of Genus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

IG Group has a beta of 0.507, meaning that its stock price is 49% less volatile than the broader market. Comparatively, Genus has a beta of 0.905, meaning that its stock price is 10% less volatile than the broader market.

In the previous week, IG Group's average media sentiment score of 0.80 beat Genus' score of 0.00 indicating that IG Group is being referred to more favorably in the media.

Company Overall Sentiment
IG Group Positive
Genus Neutral

IG Group pays an annual dividend of GBX 46.50 per share and has a dividend yield of 4.8%. Genus pays an annual dividend of GBX 32.90 per share and has a dividend yield of 1.4%. IG Group pays out 44.2% of its earnings in the form of a dividend. Genus pays out 7.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

IG Group beats Genus on 11 of the 16 factors compared between the two stocks.

How does Genus compare to WH Smith?

Genus (LON:GNS) and WH Smith (LON:SMWH) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

In the previous week, WH Smith had 9 more articles in the media than Genus. MarketBeat recorded 9 mentions for WH Smith and 0 mentions for Genus. Genus' average media sentiment score of 0.00 beat WH Smith's score of -0.02 indicating that Genus is being referred to more favorably in the media.

Company Overall Sentiment
Genus Neutral
WH Smith Neutral

Genus currently has a consensus target price of GBX 3,216.67, suggesting a potential upside of 37.82%. WH Smith has a consensus target price of GBX 566.43, suggesting a potential upside of 52.68%. Given WH Smith's higher probable upside, analysts plainly believe WH Smith is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
WH Smith
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Genus pays an annual dividend of GBX 32.90 per share and has a dividend yield of 1.4%. WH Smith pays an annual dividend of GBX 17.30 per share and has a dividend yield of 4.7%. Genus pays out 7.7% of its earnings in the form of a dividend. WH Smith pays out -17.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. WH Smith is clearly the better dividend stock, given its higher yield and lower payout ratio.

WH Smith has higher revenue and earnings than Genus. WH Smith is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genus£658.10M2.29£7.87M£425.105.49
WH Smith£1.63B0.34£63.01M-£96.70N/A

Genus has a beta of 0.905, suggesting that its share price is 10% less volatile than the broader market. Comparatively, WH Smith has a beta of 0.929, suggesting that its share price is 7% less volatile than the broader market.

55.3% of Genus shares are owned by institutional investors. Comparatively, 71.9% of WH Smith shares are owned by institutional investors. 0.8% of Genus shares are owned by insiders. Comparatively, 0.9% of WH Smith shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Genus has a net margin of 43.35% compared to WH Smith's net margin of -5.66%. Genus' return on equity of 44.90% beat WH Smith's return on equity.

Company Net Margins Return on Equity Return on Assets
Genus43.35% 44.90% 3.31%
WH Smith -5.66%-63.23%6.62%

Summary

WH Smith beats Genus on 10 of the 17 factors compared between the two stocks.

How does Genus compare to Compass Group?

Compass Group (LON:CPG) and Genus (LON:GNS) are both small-cap consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Compass Group pays an annual dividend of GBX 66.38 per share and has a dividend yield of 197.3%. Genus pays an annual dividend of GBX 32.90 per share and has a dividend yield of 1.4%. Compass Group pays out 55.9% of its earnings in the form of a dividend. Genus pays out 7.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Genus has a net margin of 43.35% compared to Compass Group's net margin of 4.20%. Genus' return on equity of 44.90% beat Compass Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Compass Group4.20% 26.12% 7.52%
Genus 43.35%44.90%3.31%

Compass Group has higher revenue and earnings than Genus. Compass Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Compass Group£48.49B0.01£1.35B£118.700.28
Genus£658.10M2.29£7.87M£425.105.49

Compass Group has a beta of 0.659, meaning that its stock price is 34% less volatile than the broader market. Comparatively, Genus has a beta of 0.905, meaning that its stock price is 10% less volatile than the broader market.

Compass Group currently has a consensus target price of GBX 2,937.14, suggesting a potential upside of 8,631.10%. Genus has a consensus target price of GBX 3,216.67, suggesting a potential upside of 37.82%. Given Compass Group's higher probable upside, equities analysts clearly believe Compass Group is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Compass Group
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Compass Group's average media sentiment score of 0.00 equaled Genus'average media sentiment score.

Company Overall Sentiment
Compass Group Neutral
Genus Neutral

68.2% of Compass Group shares are owned by institutional investors. Comparatively, 55.3% of Genus shares are owned by institutional investors. 0.5% of Compass Group shares are owned by insiders. Comparatively, 0.8% of Genus shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Genus beats Compass Group on 8 of the 15 factors compared between the two stocks.

How does Genus compare to ALLG.L?

Genus (LON:GNS) and ALLG.L (LON:ALLG) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Genus has a net margin of 43.35% compared to ALLG.L's net margin of 0.00%. Genus' return on equity of 44.90% beat ALLG.L's return on equity.

Company Net Margins Return on Equity Return on Assets
Genus43.35% 44.90% 3.31%
ALLG.L N/A N/A N/A

Genus has higher revenue and earnings than ALLG.L.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genus£658.10M2.29£7.87M£425.105.49
ALLG.LN/AN/AN/AN/AN/A

In the previous week, Genus' average media sentiment score of 0.00 equaled ALLG.L'saverage media sentiment score.

Company Overall Sentiment
Genus Neutral
ALLG.L Neutral

Genus presently has a consensus target price of GBX 3,216.67, suggesting a potential upside of 37.82%. Given Genus' stronger consensus rating and higher possible upside, analysts clearly believe Genus is more favorable than ALLG.L.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
ALLG.L
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

55.3% of Genus shares are held by institutional investors. 0.8% of Genus shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Genus beats ALLG.L on 9 of the 9 factors compared between the two stocks.

How does Genus compare to CVS Group?

CVS Group (LON:CVSG) and Genus (LON:GNS) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

48.5% of CVS Group shares are owned by institutional investors. Comparatively, 55.3% of Genus shares are owned by institutional investors. 1.5% of CVS Group shares are owned by company insiders. Comparatively, 0.8% of Genus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CVS Group has a beta of 1.044, indicating that its share price is 4% more volatile than the broader market. Comparatively, Genus has a beta of 0.905, indicating that its share price is 10% less volatile than the broader market.

Genus has a net margin of 43.35% compared to CVS Group's net margin of 2.43%. Genus' return on equity of 44.90% beat CVS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Group2.43% 5.91% 5.03%
Genus 43.35%44.90%3.31%

CVS Group has higher revenue and earnings than Genus. Genus is trading at a lower price-to-earnings ratio than CVS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Group£712.80M1.32£20.68M£24.3058.02
Genus£658.10M2.29£7.87M£425.105.49

In the previous week, CVS Group had 1 more articles in the media than Genus. MarketBeat recorded 1 mentions for CVS Group and 0 mentions for Genus. CVS Group's average media sentiment score of 0.00 equaled Genus'average media sentiment score.

Company Overall Sentiment
CVS Group Neutral
Genus Neutral

CVS Group currently has a consensus target price of GBX 1,666.67, suggesting a potential upside of 18.20%. Genus has a consensus target price of GBX 3,216.67, suggesting a potential upside of 37.82%. Given Genus' stronger consensus rating and higher probable upside, analysts clearly believe Genus is more favorable than CVS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

CVS Group pays an annual dividend of GBX 8.50 per share and has a dividend yield of 0.6%. Genus pays an annual dividend of GBX 32.90 per share and has a dividend yield of 1.4%. CVS Group pays out 35.0% of its earnings in the form of a dividend. Genus pays out 7.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Genus is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Genus beats CVS Group on 9 of the 17 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNS vs. The Competition

MetricGenusDiversified Consumer Services IndustryConsumer Discretionary SectorLON Exchange
Market Cap£1.47B£4.33B£12.98B£2.81B
Dividend Yield1.54%2.91%3.12%5.11%
P/E Ratio5.3723.6226.0923.22
Price / Sales2.241.261.725.16
Price / Cash50.5613.3315.3820.23
Price / Book2.762.343.512.42
Net Income£7.87M£240.88M£445.33M£5.88B
7 Day Performance-2.31%-1.69%-1.76%-0.97%
1 Month Performance-1.38%-7.52%-1.44%-2.67%
1 Year Performance-6.25%-7.57%-1.18%6.74%

Genus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNS
Genus
2.6603 of 5 stars
GBX 2,272
-2.6%
GBX 3,216.67
+41.6%
-2.9%£1.47B£658.10M5.34480
IGG
IG Group
4.5706 of 5 stars
GBX 958.50
+1.5%
GBX 1,537.50
+60.4%
-10.1%£3.16B£949.10M9.122,754
SMWH
WH Smith
2.1068 of 5 stars
GBX 414.20
-0.2%
GBX 566.43
+36.8%
-40.7%£623.37M£1.59BN/A14,935
CPG
Compass Group
N/AGBX 32.95
-0.5%
GBX 2,937.14
+8,813.9%
-98.6%£560.25M£48.49B0.28550,000
ALLG
ALLG.L
N/AGBX 7.93
+1.3%
N/AN/A£0.00N/AN/A140

Related Companies and Tools


This page (LON:GNS) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners